The Global Head and Neck Cancer Diagnostics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report, the Head and Neck Cancer Diagnostics Market is estimated to be USD 6, 672 Million in 2015 and predicted to rise to USD 11,508 million by 2020 with a CAGR of 11.52%. The market is segmented by Test Type (Diagnostic imaging, Biopsy, Endoscopy and Dental diagnostics). Further, the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The global market for head and neck cancer diagnostics is predicted to show high growth rate, mainly due to the upsurge incidence of the disease worldwide. Though this form of cancer is not prevalent in all its forms in developed countries like USA, it has increased its presence and incidence in countries of Asia, Africa and to some extent Europe, making its screening and early detection of high importance for appropriate treatment and care.
Escalation in the global geriatric population that led to the prevalence of chronic diseases which include head and neck related cancers, growing awareness about cancers, and rise in the healthcare expenditure of people and government are fueling the global Head and Neck Cancer Diagnostic Market. However, the low adoption rate of digital technology based systems, conventional CT and MRI scanners, excise duty imposed on sale of medical devices in mature markets
Some of the key players operating in the global head and neck cancer diagnostics market are Philips Healthcare, Varian Medical Systems, Siemens Healthcare, GE Healthcare, Shimadzu Corporation, Identafi, Velscope VX, AdDent Inc.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/head-and-neck-cancer-diagnostics-market-49/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.